Skip to content

Effect of preventive precise multimodal analgesia on chronic pain control in adult patients undergoing thoracoscopic pulmonary resection and possible mechanisms

Effect of preventive precise multimodal analgesia on chronic pain control in adult patients undergoing thoracoscopic pulmonary resection and possible mechanisms

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082072
Enrollment
Unknown
Registered
2024-03-20
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Diseases

Interventions

Group I:Preventive multimodal analgesia
Group II:Traditional multimodal analgesia

Sponsors

Xuanwu Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adult patients aged 18-65 years; 2. Adult patients undergoing elective thoracoscopic lobectomy or segmental lung resection under general anesthesia; 3. ASA classification I to III; 4. BMI of 18.5 to 29.9 kg/m2; 5. Informed patient consent obtained.

Exclusion criteria

Exclusion criteria: 1. History of surgery under general anesthesia within one month prior to surgery; 2. Preoperative coexisting severe cardiopulmonary and cerebral systemic diseases, such as severe hypertension (crisis), severe diabetes (ketosis, acidosis), coronary artery disease, COPD, asthma, respiratory failure, pulmonary hypertension, severe arrhythmias (atrial fibrillation, atrioventricular block of degree II or higher, sick sinus syndrome, etc.), severe heart valve disease, heart failure, renal failure Patients with stroke, myocardial infarction within 6 months, Alzheimer's disease, Parkinson's disease, psychiatric disease, OSAS, myasthenia gravis, etc.; 3. History of chronic pain; 4. Hepatic and renal insufficiency and leukopenia; 5. History of allergy to the drugs used in this study; 6. History of inflammatory bowel disease or peptic ulcer; 7. Coagulation abnormalities; 8. Patients with METs < 4; 9. Patients who refused or were unable to cooperate in this study; 10. Participating in other studies within 30 days.

Design outcomes

Primary

MeasureTime frame
The incidence of chronic pain;

Secondary

MeasureTime frame
Acute postoperative pain;Effects of chronic pain on anxiety and sleep;

Countries

China

Contacts

Public ContactTianlong Wang

Xuanwu Hospital, Capital Medical University

w_tl5595@hotmail.com+86 139 1052 5304

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026